background
coronavirus
caus
broad
rang
diseas
anim
human
human
coronaviru
hcov
associ
common
cold
viral
plaqu
assay
enabl
character
viru
infect
allow
purifi
viru
stock
solut
essenti
drug
screen
hitherto
use
cell
cultur
show
low
level
viru
replic
weak
diffus
cytopathogen
effect
yet
possibl
establish
practic
plaqu
assay
import
human
pathogen
result
differ
cell
cultur
test
suscept
infect
human
colon
carcinoma
cell
replic
viru
fold
effici
commonli
use
african
green
monkey
kidney
cell
cell
show
cytopathogen
effect
day
post
infect
avicel
agaros
carboxymethylcellulos
overlay
prove
suitabl
plaqu
assay
best
result
achiev
avicel
produc
larg
clear
plaqu
th
day
infect
util
plaqu
assay
agros
overlay
demonstr
purifi
viru
therebi
increas
viral
infect
log
pfuml
cell
support
better
cell
enabl
cytopathogen
plaqu
assay
avicel
overlay
favour
plaqu
quantif
agaros
overlay
prefer
plaqu
purif
viru
stock
increas
infect
benefici
antivir
screen
anim
model
diseas
experiment
task
coronavirus
larg
envelop
plusstrand
rna
virus
current
classifi
three
group
presumpt
genera
group
divid
two
phylogenet
clade
exemplifi
transmiss
gastroenter
viru
tgev
porcin
epidem
diarrhoea
viru
pedv
respect
latter
clade
contain
two
prototyp
human
coronavirus
hcov
term
like
group
group
contain
mammalian
cov
includ
two
human
pathogen
prototyp
term
sever
import
anim
pathogen
bovin
cov
murin
hepat
viru
well
sarscov
group
contain
foremostli
avian
cov
well
recent
identifi
major
caus
common
cold
wintertim
isol
african
green
monkey
kidney
cell
seven
month
old
infant
bronchiol
conjunct
investig
viru
predominantli
detect
children
respiratori
infect
children
respiratori
diseas
yield
rel
high
preval
could
becom
import
model
screen
anticoronavir
agent
sever
studi
suggest
eg
hcov
proteas
inhibitor
would
crossreact
among
differ
hcov
antivir
screen
reli
detect
replic
viru
cell
cultur
experiment
task
plaqu
assay
proven
simpl
applic
efficaci
repres
viru
viabil
plaqu
assay
make
use
viscou
overlay
cover
cell
immedi
infect
thu
limit
viru
spread
restrict
viru
growth
foci
cell
site
initi
infect
viru
contribut
low
cytopath
effect
cell
foci
may
visual
immunostain
viru
induc
strong
cytopathogen
effect
cpe
cell
plaqu
lyse
plaqu
visual
stain
residu
intact
cell
cytopathogen
plaqu
assay
compat
high
throughput
screen
facilit
plaqu
purif
clone
viru
turn
help
obtain
viru
stock
optim
infect
eg
decreas
amount
defect
interf
di
particl
accumul
serial
passag
cov
import
technic
achiev
made
studi
replic
includ
recent
develop
infecti
cdna
clone
still
major
obstacl
replic
slowli
rel
low
titr
current
cell
cultur
cell
viru
contribut
weak
diffus
cpe
cell
cytopath
plaqu
assay
avail
nonrecombin
viru
although
seem
replic
upper
lower
airway
mani
cov
predominantli
infect
enter
tract
tgev
pedv
felin
enter
cov
bovin
coronaviru
sarscov
detect
faecal
swab
sar
patient
sarscov
shown
replic
colon
carcinoma
cell
routin
use
grow
enteroand
adeno
astrovirus
interestingli
sarscov
shown
use
receptor
viru
entri
angiotensin
convert
enzym
show
cell
highli
suscept
infect
viru
propag
cell
much
effici
cell
test
differ
overlay
assay
format
develop
cytopathogen
plaqu
assay
use
analyt
prepar
purpos
vero
cell
caus
clear
cpe
infect
viru
use
receptor
sarscov
differ
cell
cultur
suscept
sarscov
infect
test
suscept
tabl
cell
sixwel
plate
infect
plaqueform
unit
viru
stock
np
rna
concentr
supernat
measur
short
viru
adsorpt
ie
fresh
medium
wash
infect
supernat
day
later
tabl
increas
viru
rna
less
seven
cultur
interestingli
includ
prototyp
cell
cultur
spite
low
amplif
factor
cell
show
usual
weak
cpe
typic
observ
infect
vero
cell
seem
support
viru
growth
effici
produc
cpe
interestingli
remark
differ
vero
vero
fm
cell
tabl
hand
cell
also
show
differ
growth
sarscov
vero
fm
consist
show
pronounc
cpe
vero
signific
differ
rna
amplif
shown
cell
amplifi
viru
rna
effici
show
clearli
visibl
cpe
start
day
infect
cell
becam
round
detach
surfac
show
morpholog
sign
cell
death
figur
confirm
differenti
replic
effici
cell
infect
parallel
cell
line
seed
cm
flask
infect
multipl
infect
sampl
supernat
taken
daili
day
analyz
real
time
rtpcr
shown
figur
cell
replic
viru
effici
day
onward
rna
concentr
fold
higher
cell
clear
cpe
observ
cell
cell
test
util
cytopathogen
plaqu
assay
three
overlay
techniqu
commonli
use
plaqu
assay
test
suitabl
cell
infect
plate
one
hour
supernat
remov
cell
wash
pb
overlaid
follow
cmc
overlay
ml
fresh
dmem
ad
well
subsequ
ml
cmc
solut
slowli
ad
per
well
agaros
overlay
final
concentr
prepar
melt
agaros
cool
water
bath
mix
immedi
applic
equal
volum
dmem
store
room
temperatur
two
ml
mixtur
care
appli
well
avicel
overlay
made
mix
avicel
solut
equal
volum
dmem
ml
mixtur
immedi
ad
well
plaqu
assay
incub
without
disturb
co
overlay
remov
day
five
cell
fix
solut
formaldehyd
pb
visibl
three
overlay
stain
clearest
avicel
cultur
cell
take
day
first
sign
weak
cpe
becom
visibl
order
test
whether
incub
time
could
reduc
cell
five
plaqu
assay
viru
dilut
seri
done
avicel
overlay
termin
fixat
day
respect
day
plaqu
visibl
shown
termin
day
yield
plaqu
high
viru
concentr
figur
day
onward
plaqu
visibl
lowest
detect
viru
concentr
plaqu
day
larger
increas
number
work
complic
low
infecti
titer
viru
stock
solut
order
obtain
infecti
viru
solut
standard
viru
stock
np
see
materi
method
section
plaquepurifi
use
agaros
overlay
life
stain
cell
neutral
red
solut
success
cell
shown
use
altern
techniqu
plaqu
prepar
limit
dilut
infect
done
plate
day
cytopath
foci
identifi
scan
well
invert
microscop
low
magnif
light
clear
agaros
overlay
posit
cpe
foci
mark
perman
marker
help
turn
microscop
light
agaros
overlay
penetr
pipett
fluid
aspir
underneath
overlay
fluid
resuspend
opti
pro
serumfre
medium
serv
start
solut
new
limit
dilut
infect
seri
next
plate
plaqu
assay
three
round
purif
growth
kinet
cell
done
last
round
aspir
fluid
inocul
ml
opti
pro
serumfre
medium
overlaid
confluent
cell
cm
flask
infect
infect
one
hour
wash
ml
dmem
ad
flask
incub
co
four
day
stock
harvest
store
describ
origin
stock
materi
method
section
purifi
viru
hereaft
refer
pp
plaquepurifi
compar
infect
plaquepurifi
viru
origin
viru
stock
see
materi
method
section
viral
titr
determin
avicel
plaqu
assay
shown
figur
pp
infecti
np
plaqu
assay
repeat
three
time
shown
mean
titr
determin
pfuml
pfu
ml
respect
pp
np
absolut
quantif
viru
rna
realtim
rtpcr
yield
rna
copiesml
pp
copiesml
np
interest
note
viru
stock
rather
high
rna
concentr
oppos
infect
pfurna
ratio
pp
np
high
excess
rna
infecti
unit
might
attribut
viru
harvest
procedur
possibl
releas
nonpackag
rna
along
viru
particl
freezethaw
pfurna
ratio
similar
stock
appear
unlik
elimin
defect
interf
particl
contribut
gain
infect
interest
futur
studi
see
whether
might
adapt
cell
plaqu
purif
cell
seem
support
replic
significantli
better
hitherto
use
cultur
cell
applic
cytopathogen
plaqu
assay
facilit
quantif
infect
enabl
studi
use
plaqu
morpholog
short
incub
time
day
compat
highthroughput
applic
drug
screen
use
avicel
overlay
favour
plaqu
quantif
wherea
agaros
overlay
prefer
plaqu
purif
viru
stock
increas
infect
benefici
antivir
screen
anim
model
diseas
experiment
task
tabl
passag
cell
detach
use
trypsinedta
paa
except
cell
routin
subcultur
scrape
pipet
mechan
resuspens
plaqu
assay
cell
use
differ
overlay
figur
plaqu
assay
cell
use
differ
overlay
serial
dilut
cell
h
viru
adsorbt
differ
overlay
ad
day
cell
fix
formaldehyd
stain
crystal
violet
solut
carboxymethylcellulos
b
agaros
c
avicel
plaqu
assay
differ
incub
time
cell
seed
plate
approxim
cell
per
well
incub
monolay
confluent
cell
grown
confluenc
prior
infect
cell
wash
phosphat
buffer
salin
pb
viru
inoculum
gibco
opti
pro
serum
free
medium
invitrogen
karlsruh
germani
plu
penicillinstreptomycin
paa
lglutamin
paa
ad
well
inoculum
remov
one
hour
incub
cell
wash
twice
pb
supplement
ml
dmem
per
well
viral
rna
extract
cell
cultur
supernat
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
real
time
rtpcr
absolut
viru
rna
quantif
perform
describ
previous
wv
suspens
avicel
fcm
biopolym
brussel
belgium
prepar
distil
water
autoclav
min
wv
suspens
agaros
plaqu
agaros
biozym
hessisch
oldendorf
germani
prepar
distil
water
autoclav
carboxymethyl
cellulos
cmc
solut
prepar
autoclav
cmc
powder
bdh
pool
uk
magnet
stirrer
autoclav
powder
hydrat
dmem
wv
stir
overnight
homogen
doubl
concentr
dulbecco
modifi
eagl
medium
dmem
prepar
mix
dmem
paa
gl
dmem
powder
biochrom
berlin
germani
supplement
foetal
bovin
serum
gold
paa
penicillinstreptomycin
concentr
penicillin
